|
Red wine slows lung cancer, white
raises risk
London -
Drinking red wine could protect against lung cancer, but white wine
may increase the risk, Spanish scientists said Thursday.
They examined the effects of
different types of wine on lung cancer, the most common and deadly
form of the disease.
"Consumption of red wine ... was
associated with a slight but statistically significant reduction in
the development of lung cancer," said research team leader Professor
Juan Barros-Dios in the study published in scientific journal Thorax.
Red wine contains tannins and
resveratrol, substances which he said could explain the drink's
anti-cancer properties.
Tannins act as antioxidants, which
mop up free radicals -- particles harmful to cells. Resveratrol is
known to fight cancer tumor growth.
"In terms of the daily number of
glasses, white wine appeared to increase the risk," Barros-Dios said
in the journal.
But the scientists emphasized the
risk from drinking white wine was very slight and only 39 white wine
drinkers were studied.
The study concluded the increased
risk from drinking white wine was because of the ethanol it contained.
All wine contains the chemical, which
is a gene mutator, but in red wine the anti-lung cancer benefits
outweighed possible gene damage from the ethanol, the researchers
said.
However, Barros-Dios was careful not
to encourage binge drinking to combat lung cancer, which the latest
World Health Organization figures show killed 1.2 million people in
2000.
"It would be extremely risky -- and
even dangerous -- for recommendations to be drawn up endorsing high
consumption of red wine for the prevention of lung cancer," he said.
Research colleague Dr Alberto
Ruano-Ravina said the aim of the study was to investigate red wine's
anti-cancer components, not determine how much wine would ward off
cancer.
"We do not recommend drinking if you
want to prevent lung cancer," he told Reuters, adding that the risk of
lung cancer to non-smokers is very small, and that smokers should
quit.
The effects of wine drinking were
studied in 132 people with lung cancer and 187 people in hospital for
non-tobacco related minor surgery in the Santiago de Compostela
district, in northwestern Spain.
Barros-Dios,
Ruano-Ravina and research colleague Adolfo Figueiras are affiliated to
the University of Santiago de Compostela. They said they will continue
their studies using lab animals. --
Reuters
Click
Here To Have Your Say On This Story
Brudirect.com News
|